Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Up 3.71%

Abbott Laboratories reported an earnings per share of $1.14, exceeding expectations slightly. The stock reacted positively, rising 3.71%, likely reflecting investor confidence in the company's performance despite the absence of revenue data and guidance. The lack of additional commentary from management leaves some uncertainty about future directions.